oral
administr
specif
antibodi
attract
approach
establish
protect
immun
gastrointestin
pathogen
human
anim
increas
number
antibioticresist
bacteria
emphas
need
find
altern
antibiot
immunotherapi
also
use
pathogen
difficult
treat
tradit
antibiot
lay
hen
good
produc
specif
antibodi
immun
specif
antibodi
transport
egg
yolk
antibodi
purifi
lay
hen
produc
g
yolk
antibodi
igi
per
year
antibodi
also
biochem
properti
make
attract
peror
immunotherapi
neither
activ
mammalian
complement
interact
mammalian
fc
receptor
could
mediat
inflammatori
respons
gastrointestin
tract
egg
also
normal
dietari
compon
thu
practic
risk
toxic
side
effect
igi
yolk
antibodi
shown
sever
studi
prevent
bacteri
viral
infect
increas
preval
antibioticresist
bacteria
make
tradit
antibiot
less
effect
thu
import
find
altern
use
antibiot
oral
immunotherapi
specif
antibodi
treatment
strategi
activ
pursu
laboratori
studi
earlystag
clinic
studi
last
decad
sever
sourc
antibodi
use
studi
includ
human
igg
monoclon
antibodi
bovin
colostrum
chicken
egg
yolk
antibodi
polyclon
antibodi
recogn
epitop
bacteri
surfac
make
difficult
bacteria
avoid
antibodi
mutat
also
cheaper
produc
monoclon
antibodi
egg
yolk
interest
sourc
specif
antibodi
oral
immunotherapi
hen
immun
microb
respond
produc
specif
antibodi
microb
antibodi
activ
transport
egg
yolk
larg
quantiti
blood
lay
hen
lay
hen
produc
yolk
antibodi
rabbit
produc
time
period
anim
care
cost
lower
chicken
compar
rabbit
egg
yolk
antibodi
thu
inexpens
way
produc
larg
amount
specif
antibodi
chicken
antibodi
offer
mani
advantag
tradit
mammalian
antibodi
use
detect
mammalian
antigen
owe
evolutionari
differ
chicken
igi
react
epitop
mammalian
antigen
give
amplif
signal
chicken
antibodi
also
use
avoid
interfer
immunolog
assay
caus
human
complement
system
rheumatoid
factor
human
antimous
igg
antibodi
hama
human
bacteri
fc
receptor
antibodi
purifi
larg
amount
egg
yolk
make
lay
hen
highli
effici
produc
polyclon
antibodi
sever
studi
show
bacteri
viral
infect
prevent
egg
yolk
immunoglobulin
igi
dosedepend
manner
peror
administr
specif
antibodi
egg
yolk
use
success
treat
bacteri
viral
infect
anim
lowmolecularweight
serum
antibodi
found
bird
igi
wherea
mammal
igg
igi
main
serum
immunoglobulin
chicken
chicken
igi
chicken
igg
call
earlier
function
equival
mammalian
igg
bird
differ
mani
function
aspect
mammalian
igg
chicken
igi
consist
two
light
chain
two
heavi
chain
molecular
weight
approx
da
heavi
chain
upsilon
weight
da
light
chain
da
igi
transport
mother
embryo
via
egg
yolk
egg
yolk
thu
contain
high
concentr
chicken
igi
immunoglobulin
class
present
neglig
amount
egg
yolk
igi
concentr
egg
yolk
higher
serum
concentr
singl
egg
yolk
approx
ml
contain
mg
igi
use
chicken
egg
yolk
sourc
antibodi
product
repres
reduct
anim
use
chicken
produc
larger
amount
antibodi
laboratori
rodent
also
make
possibl
elimin
collect
blood
pain
anim
european
centr
valid
altern
method
ecvam
thu
recommend
yolk
antibodi
use
instead
mammalian
antibodi
anim
welfar
reason
antibodi
react
antigen
immun
complex
form
antigenantibodi
complex
contain
mammalian
antibodi
activ
human
complement
system
activ
complement
compon
potent
inflammatori
mediat
theoret
immun
complex
contain
mammalian
antibodi
may
interact
fc
complement
receptor
mammalian
gastrointestin
tract
caus
cell
activ
immun
complex
contain
igi
activ
mammalian
complement
system
interact
mammalian
fc
complement
receptor
summari
yolk
igi
seem
well
suit
peror
immunotherapi
transit
time
oral
administ
antibodi
gastrointestin
tract
h
infant
children
oral
administ
antibodi
subject
denatur
acid
ph
stomach
degrad
proteas
neonat
gastric
fluid
ph
close
neutral
ph
rapidli
decreas
first
day
studi
shown
part
antibodi
remain
intact
pepsin
trypsin
digest
consider
cleavag
antibodi
fab
fab
fc
fragment
howev
fab
fab
fragment
still
capabl
bind
antigen
exhibit
neutral
activ
despit
degrad
gastrointestin
tract
activ
antibodi
still
detect
stool
sampl
percentag
activ
antibodi
stool
vari
low
level
oral
given
dose
differ
studi
differ
probabl
due
differ
ph
stomach
enzym
activ
presenc
antigen
gastrointestin
passag
time
method
use
detect
antibodi
stool
may
also
influenc
result
larg
portion
antibodi
digest
fab
fab
fragment
fragment
still
bind
antigen
mani
immunolog
test
give
differ
result
fab
fragment
whole
antibodi
antibodi
absorb
intestin
young
piglet
calv
low
level
igi
detect
circul
calv
piglet
treat
oral
yolk
antibodi
first
h
post
natum
time
period
absorpt
activ
antibodi
gastrointestin
tract
absorpt
intact
antibodi
shown
human
blum
et
al
eibl
et
al
show
increas
serum
immunoglobulin
level
oral
administr
human
immunoglobulin
infant
also
losonski
et
al
could
detect
highmolecularweight
radioact
blood
oral
administr
ilabel
igg
thu
system
effect
expect
oral
administr
yolk
antibodi
human
consumpt
egg
accept
cultur
egg
normal
dietari
compon
practic
risk
toxic
side
effect
igi
mean
egg
consumpt
eggd
sweden
amount
igi
similar
higher
amount
use
sever
immunotherapi
studi
howev
allerg
reaction
eggderiv
immunoglobulin
residu
egg
protein
may
occur
import
consid
egg
allergi
start
immunotherapi
yolk
antibodi
human
oral
administr
spray
dri
yolk
antibodi
specif
salmonella
typhimurium
dublin
shown
prevent
salmonella
infect
calv
antibodi
administ
three
time
day
inocul
typhimurium
dublin
calv
control
group
die
wherea
diarrhea
fever
observ
group
treat
highest
antibodi
titer
thu
antibodi
could
protect
fatal
salmonellosi
yolk
prepar
chicken
immun
purifi
outer
membran
protein
lipopolysaccharid
flagella
fimbria
salmonella
also
test
mous
model
experiment
salmonellosi
mice
treat
specif
antibodi
significantli
higher
surviv
rate
mice
fed
normal
egg
yolk
antibodi
yolk
immunoglobulin
also
use
protect
neonat
piglet
experiment
enterotoxigen
escherichia
coli
infect
oral
treatment
antibodi
prepar
fimbrial
adhesin
consider
reduc
sever
diarrhea
reduc
mortal
yolk
immunoglobulin
also
shown
prevent
diarrhea
rabbit
challeng
e
coli
mouth
rins
contain
egg
yolk
antibodi
streptococcu
mutan
use
reduc
establish
bacteria
dental
plaqu
human
antibodi
inhibit
mutan
adher
salivaco
hydroxyapatit
disc
vitro
decreas
percentag
mutan
per
total
streptococci
vivo
also
shown
gargl
day
yolk
prepar
specif
pseudomona
aeruginosa
prevent
colon
bacteria
lung
patient
cystic
fibrosi
one
patient
treat
yr
without
chronic
colon
p
aeruginosa
egg
yolk
colostrum
powder
contain
specif
antibodi
bovin
coronaviru
bcv
antigen
evalu
challeng
model
standard
dose
virul
bcv
strain
daili
treatment
antibodi
prepar
start
h
postchalleng
control
calv
receiv
antibodi
sever
diarrhea
die
within
infect
contrast
calv
fed
milk
contain
egg
yolk
colostrum
high
antibodi
titer
surviv
posit
weight
gain
studi
show
specif
antibodi
prepar
protect
bcvinduc
diarrhea
neonat
calv
egg
yolk
use
provid
higher
degre
protect
compar
colostrum
powder
titer
basi
field
trial
oral
administr
chicken
igi
specif
bovin
rotaviru
brv
result
significantli
increas
mean
bodi
weight
p
decreas
number
calv
shed
high
titer
brv
stool
compar
control
calv
p
oral
administ
yolk
immunoglobulin
also
shown
protect
suckl
mice
experiment
bovin
rotavirusinduc
diarrhea
oral
treatment
bovin
antirotaviru
colostrum
result
reduct
rotavirusassoci
diarrhea
infant
also
reduc
infect
rate
children
cryptosporidium
zoonot
pathogen
infect
respiratori
gastrointestin
tract
larg
number
host
includ
fish
bird
reptil
mammal
cryptosporidium
infect
usual
associ
immunosuppress
host
infect
may
also
occur
individu
normal
immun
system
use
yolk
prepar
high
anticryptosporidium
activ
caus
signific
parasit
reduct
neonat
mous
model
treatment
bovin
anticryptosporidium
colostrum
immunoglobulin
also
shown
induc
reduct
oocyt
excret
healthi
human
volunt
lay
hen
costeffici
method
product
larg
quantiti
specif
antibodi
yolk
antibodi
activ
mammalian
complement
system
interact
mammalian
fc
receptor
could
mediat
inflammatori
respons
gastrointestin
tract
egg
also
normal
dietari
compon
thu
practic
risk
toxic
side
effect
igi
oral
immunotherapi
yolk
antibodi
thu
attract
approach
treatment
gastrointestin
infect
human
anim
difficult
treat
tradit
antibiot
increas
number
antibiot
resist
bacteria
emphas
need
find
altern
antibiot
